Cabaletta Bio (CABA) Cash from Financing Activities (2018 - 2025)

Cabaletta Bio's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $8.3 million for Q4 2025.

• On a quarterly basis, Cash from Financing Activities rose 90.58% year-over-year to $8.3 million in Q4 2025; TTM through Dec 2025 was $100.3 million, a 759.36% increase from a year earlier, with the FY2025 full-year figure at $100.3 million, up 759.36% from the prior year.
• Cash from Financing Activities climbed to $8.3 million in Q4 2025 per CABA's latest filing, from -$806000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $94.3 million in Q2 2023 and bottomed at -$806000.0 in Q3 2025.
• The 5-year median for Cash from Financing Activities is $4.4 million (2024), against an average of $20.1 million.
• Across the five-year window, Cash from Financing Activities jumped 235545.0% in 2023 and slumped 1235.21% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $13.6 million in 2021, then soared by 141.35% to $32.9 million in 2022, then jumped by 182.9% to $93.0 million in 2023, then tumbled by 95.3% to $4.4 million in 2024, then soared by 90.58% to $8.3 million in 2025.
• Per Business Quant, the three latest CABA Cash from Financing Activities figures stand at $8.3 million (Q4 2025), -$806000.0 (Q3 2025), and $93.4 million (Q2 2025).